Stephen L. Rawlings

Array ( [id] => 6280022 [patent_doc_number] => 20100119452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'SCREENING METHOD' [patent_app_type] => utility [patent_app_number] => 12/451933 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6931 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119452.pdf [firstpage_image] =>[orig_patent_app_number] => 12451933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310804 [patent_doc_number] => 20090018085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Use of a GnRH antagonist peptide in the treatment of sex hormone-dependent diseases' [patent_app_type] => utility [patent_app_number] => 12/155897 [patent_app_country] => US [patent_app_date] => 2008-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3494 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018085.pdf [firstpage_image] =>[orig_patent_app_number] => 12155897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367738 [patent_doc_number] => 20090305297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Tyrosine phosphorylation sites' [patent_app_type] => utility [patent_app_number] => 12/157179 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 34137 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305297.pdf [firstpage_image] =>[orig_patent_app_number] => 12157179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4556589 [patent_doc_number] => 07838251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-23 [patent_title] => 'Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/125664 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12751 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/838/07838251.pdf [firstpage_image] =>[orig_patent_app_number] => 12125664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6412288 [patent_doc_number] => 20100166737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'P38Alpha as a Therapeutic Target in Bladder Carcinoma' [patent_app_type] => utility [patent_app_number] => 12/597785 [patent_app_country] => US [patent_app_date] => 2008-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9381 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166737.pdf [firstpage_image] =>[orig_patent_app_number] => 12597785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 62272 [patent_doc_number] => 07763248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-27 [patent_title] => 'Humanized collagen antibodies and related methods' [patent_app_type] => utility [patent_app_number] => 12/117642 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 25115 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 310 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763248.pdf [firstpage_image] =>[orig_patent_app_number] => 12117642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5559178 [patent_doc_number] => 20090270755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'PEDOMETER FOR THE BRAIN' [patent_app_type] => utility [patent_app_number] => 12/111408 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8174 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270755.pdf [firstpage_image] =>[orig_patent_app_number] => 12111408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314088 [patent_doc_number] => 20100111932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'ANTIBODIES AGAINST RAMP3' [patent_app_type] => utility [patent_app_number] => 12/597269 [patent_app_country] => US [patent_app_date] => 2008-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12714 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111932.pdf [firstpage_image] =>[orig_patent_app_number] => 12597269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886914 [patent_doc_number] => 20080261246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A CANCER MARKER AND POSTOPERATIVE MARKER FOR MINIMAL RESIDUAL DISEASE OR RECURRENT DISEASE IN PATIENTS WITH A PRIOR HISTORY OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/101661 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 20112 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261246.pdf [firstpage_image] =>[orig_patent_app_number] => 12101661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791651 [patent_doc_number] => 20080292624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Method of detecting and treating tuberous sclerosis complex associated disorders' [patent_app_type] => utility [patent_app_number] => 12/080362 [patent_app_country] => US [patent_app_date] => 2008-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24137 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292624.pdf [firstpage_image] =>[orig_patent_app_number] => 12080362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758895 [patent_doc_number] => 20080311121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'ANTIBODY ANTAGONISTS OF VE-CADHERIN WITHOUT ADVERSE EFFECTS ON VASCULAR PERMEABILITY' [patent_app_type] => utility [patent_app_number] => 12/056116 [patent_app_country] => US [patent_app_date] => 2008-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8996 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311121.pdf [firstpage_image] =>[orig_patent_app_number] => 12056116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5322919 [patent_doc_number] => 20090060909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'ANTIBODY ANTAGONISTS OF VE-CADHERIN WITHOUT ADVERSE EFFECTS ON VASCULAR PERMEABILITY' [patent_app_type] => utility [patent_app_number] => 12/056173 [patent_app_country] => US [patent_app_date] => 2008-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8999 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060909.pdf [firstpage_image] =>[orig_patent_app_number] => 12056173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852008 [patent_doc_number] => 20080317750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'ANTIBODY ANTAGONISTS OF VE-CADHERIN WITHOUT ADVERSE EFFECTS ON VASCULAR PERMEABILITY' [patent_app_type] => utility [patent_app_number] => 12/056146 [patent_app_country] => US [patent_app_date] => 2008-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9006 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317750.pdf [firstpage_image] =>[orig_patent_app_number] => 12056146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314157 [patent_doc_number] => 20100111944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHOD OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER' [patent_app_type] => utility [patent_app_number] => 12/532563 [patent_app_country] => US [patent_app_date] => 2008-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18301 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111944.pdf [firstpage_image] =>[orig_patent_app_number] => 12532563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6429630 [patent_doc_number] => 20100143245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'USES OF MONOCLONAL ANTIBODY 8H9' [patent_app_type] => utility [patent_app_number] => 12/531828 [patent_app_country] => US [patent_app_date] => 2008-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6355 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143245.pdf [firstpage_image] =>[orig_patent_app_number] => 12531828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 62271 [patent_doc_number] => 07763247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-27 [patent_title] => 'Humanized collagen antibodies and related methods' [patent_app_type] => utility [patent_app_number] => 12/070146 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24915 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 333 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763247.pdf [firstpage_image] =>[orig_patent_app_number] => 12070146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935933 [patent_doc_number] => 20110212084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'BINDING MEMBERS FOR IGE MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/527135 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 38215 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212084.pdf [firstpage_image] =>[orig_patent_app_number] => 12527135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6507904 [patent_doc_number] => 20100210612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'DETECTION OF ESR1 AMPLIFICATION IN ENDOMETRIUM CANCER AND OVARY CANCER' [patent_app_type] => utility [patent_app_number] => 12/595017 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13502 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210612.pdf [firstpage_image] =>[orig_patent_app_number] => 12595017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6465075 [patent_doc_number] => 20100190702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Compositions and Methods of Treating Neoplasia' [patent_app_type] => utility [patent_app_number] => 12/527164 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 85 [patent_no_of_words] => 27562 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190702.pdf [firstpage_image] =>[orig_patent_app_number] => 12527164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6582668 [patent_doc_number] => 20100129931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Anti-Methylation-Controlled J Protein Antibodies and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/449265 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 30031 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129931.pdf [firstpage_image] =>[orig_patent_app_number] => 12449265 [rel_patent_id] =>[rel_patent_doc_number] =>)